Quintiles teams with South Korean CRO; BASF sets deadline for Pronova deal;

> Quintiles is partnering with South Korea's BioCore, signing a two-year service deal to use the company's bioanalytical operations. More

> BASF says it will not re-extend its $823 million offer for Pronova beyond the Jan. 18 deadline; shareholders have until then to accept the deal. Article

> Pluristem is in the final stages of completing a new state-of-the-art manufacturing facility in Haifa, Israel. Release

> Icon ($ICLR) has elected former Amarin CEO Thomas Lynch to be its new chairman. News

> Private equity group American Capital is paying $200 million for Cambridge Major Laboratories, a Wisconsin API producer. Item

Sponsored by GenScript

Accelerate Biologics, Gene and Cell Therapy Product Development partnering with GenScript ProBio

GenScript ProBio is the bio-pharmaceutical CDMO segment of the world’s leading biotech company GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.

Suggested Articles

WCG is continuing its buyout run after acquiring clinical trial solutions firm Trifecta Clinical.

London-based uMed has raised nearly $4.8 million from U.K. and U.S. VCs to help healthcare providers participate in more clinical studies.

Amgen has teamed up with cloud-based trial solutions firm Reify Health to help boost patients into its drug studies.